The Anti-proliferative Effect of a Novel Glutaminase Inhibitor IN-3 on Prostate Cancer Cells
Objective: This study aimed to evaluate anti-cancer potential of a novel glutaminase (GLS) inhibitor IN-3 in prostate cancer cells. Methods: The cell viability upon IN-3 treatment was examined using crystal violet staining and IC50 values were calculated for cancer cell lines PC-3 and LNCaP and norm...
Saved in:
Main Authors: | Ummuhan DEMIR, Ayse Busranur CELIK |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-09-01
|
Series: | Medeniyet Medical Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-87094 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NCAPD3‐mediated AKT activation regulates prostate cancer progression
by: Yi Zhang, et al.
Published: (2025-02-01) -
LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p
by: Yongsheng Yu, et al.
Published: (2024-12-01) -
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer
by: Hikari Miura, et al.
Published: (2024-12-01) -
Variation Comparison of OLS and GLS Estimators using Monte Carlo Simulation of Linear Regression Model with Autoregressive Scheme
by: Sajid AliKhan, et al.
Published: (2021-02-01) -
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)